These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28640)

  • 1. [Recent data on the mode of action of neuroleptics].
    Bartholini G
    Actual Pharmacol (Paris); 1978; 30():35-47. PubMed ID: 28640
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems.
    Bartholini G; Stadler H; Gadea-Ciria M; Lloyd KG
    Adv Biochem Psychopharmacol; 1977; 16():391-5. PubMed ID: 18888
    [No Abstract]   [Full Text] [Related]  

  • 3. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 4. Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions.
    Di Chiara G; Morelli M; Acquas E; Carboni E
    Arzneimittelforschung; 1992 Feb; 42(2A):231-7. PubMed ID: 1586394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
    Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
    Huot S; Lippert B; Palfreyman MG; Schechter PJ
    Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurotransmitter interactions related to central dopamine neurons.
    Lloyd KG
    Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between cholinergic and catecholaminergic neurones in rat brain.
    Corrodi H; Fuxe K; Lidbrink P
    Brain Res; 1972 Aug; 43(2):397-416. PubMed ID: 4403347
    [No Abstract]   [Full Text] [Related]  

  • 9. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic studies of tardive dyskinesia.
    Chase TN; Tamminga CA
    Adv Biochem Psychopharmacol; 1980; 24():457-61. PubMed ID: 7405673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical mechanism of action of neuroleptics (author's transl)].
    Scatton B
    Encephale; 1981; 7(3):201-14. PubMed ID: 6116590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems.
    McGeer PL; McGeer EG; Hattori T
    Adv Biochem Psychopharmacol; 1977; 16():397-402. PubMed ID: 329651
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical vs clinical physiognomy of neuroleptics, with special reference to their antimanic effect.
    Dresse A
    Acta Psychiatr Belg; 1974 Sep; 74(5):485-7. PubMed ID: 4471028
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of NMDA receptors in methamphetamine-induced changes in extrapyramidal and limbic neuropeptide systems.
    Hanson GR; Singh N; Bush L; Gibb JW
    NIDA Res Monogr; 1990; 105():439. PubMed ID: 1678873
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas.
    Bartholini G; Stadler H; Ciria MG; Lloyd KG
    Neuropharmacology; 1976 Sep; 15(9):515-9. PubMed ID: 980227
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents.
    Costall B; Naylor RJ
    Neuropharmacology; 1974 May; 13(5):353-64. PubMed ID: 4607196
    [No Abstract]   [Full Text] [Related]  

  • 18. The purely neuroleptic effects and its relation to the "neuroleptic threshold".
    Haase HJ
    Acta Psychiatr Belg; 1978; 78(1):19-36. PubMed ID: 645405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties].
    Tetreault L; Filotto J; Bordeleau JM
    Can Psychiatr Assoc J; 1968 Dec; 13(6):507-12. PubMed ID: 5726835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.